IDEXX Laboratories, Inc. (OQ:IDXX)

Business Focus: Veterinary Medical Equipment & Supplies

Apr 04, 2024 04:30 pm ET
IDEXX Laboratories to Release 2024 First Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Feb 20, 2024 02:00 pm ET
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences:
Feb 15, 2024 06:00 am ET
IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect
Initial Vello Users Show an Average 19% Reduction in No-Show Rate, Enabling More Clinical Visits
Feb 15, 2024 06:00 am ET
IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect
Initial Vello Users Show an Average 19% Reduction in No-Show Rate, Enabling More Clinical Visits
Feb 05, 2024 06:30 am ET
IDEXX Announces Fourth Quarter and Full Year Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results.
Jan 23, 2024 03:30 pm ET
IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jan 12, 2024 06:05 am ET
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
Fecal Dx antigen testing will soon detect the most common intestinal parasites earlier, uncovering more infections
Jan 12, 2024 06:05 am ET
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
Fecal Dx antigen testing will soon detect the most common intestinal parasites earlier, uncovering more infections
Jan 12, 2024 06:00 am ET
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
AI-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases
Jan 12, 2024 06:00 am ET
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
AI-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases
Dec 07, 2023 04:15 pm ET
IDEXX Laboratories Schedules Two Institutional Investor Events
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events:
Nov 08, 2023 06:00 am ET
IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases
The rapid diagnostic test provides a comprehensive solution for detecting canine leishmaniosis that impacts one in 10 dogs in endemic regions
Nov 01, 2023 06:30 am ET
IDEXX Laboratories Announces Third Quarter Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.
Oct 05, 2023 04:00 pm ET
IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, November 1, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Aug 01, 2023 06:30 am ET
IDEXX Laboratories Announces Second Quarter Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results.
Jul 25, 2023 07:00 am ET
IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates
The 2022 report, "Purpose-Driven Progress," introduces a new framework that aligns IDEXX's ESG goals and initiatives with its long-term strategy and Purpose
Jul 19, 2023 04:15 pm ET
First Watch Announces Appointment of Irene Chang Britt to Board of Directors
First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the appointment of Irene Chang Britt to its Board of Directors, effective...
Jul 12, 2023 07:00 am ET
IDEXX Laboratories Elects Irene Chang Britt to Board of Directors
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Irene Chang Britt, a former executive at Campbell Soup Company, to the Company's Board of Directors, effective July 11, 2023.
Jun 29, 2023 03:00 pm ET
IDEXX Laboratories to Release 2023 Second Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jun 15, 2023 07:00 am ET
IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio
The IDEXX Cystatin B Test can help veterinarians detect kidney injury before changes in kidney function, promoting better patient outcomes
May 10, 2023 09:15 am ET
IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 2023. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:15 pm (EDT).
May 02, 2023 06:30 am ET
IDEXX Laboratories Announces First Quarter Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.
Apr 13, 2023 03:00 pm ET
IDEXX Laboratories to Release 2023 First Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 first quarter results for Tuesday, May 2, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Feb 20, 2023 06:00 am ET
Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity
Major gains possible by optimizing workflow, applying technology smartly, and improving talent management
Feb 06, 2023 08:34 am ET
Thinking about trading options or stock in Catalent, Tesla, IDEXX Laboratories, Exxon Mobil, or Regeneron Pharmaceuticals?
NEW YORK, Feb. 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTLT, TSLA, IDXX, XOM, and REGN.
Feb 06, 2023 05:30 am ET
IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
Achieves fourth quarter revenue growth of 3% reported and 7% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 8% organic  Solid growth supported by continued benefits from IDEXX execution drivers, including 13% year-over-year expansion of IDEXX's global premium instrument installed baseDelivers fourth quarter EPS of $2.05, an increase of 8% as reported and 14% on a comparable basis, supported by operating margin expansion Provides initial outlook for 2023 revenue of $3,590 million - $3,690 million, reflecting reported growth of 6.5% - 9.5% and organic growth of
Jan 26, 2023 07:15 am ET
IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
WESTBROOK, Maine, Jan. 26, 2023 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 fourth quarter and full year financial results for Monday, February 6, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Dec 22, 2022 01:35 pm ET
IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
WESTBROOK, Maine, Dec. 22, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2023. Jay Mazelsky, President and Chief Executive Officer will participate in a fireside chat at 1:15 pm ET.
Nov 01, 2022 06:30 am ET
IDEXX Laboratories Announces Third Quarter Results
Achieves third quarter revenue growth of 4% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 5% reported and 9% organic, building on high prior year growthContinued strong demand for diagnostic services and excellent commercial execution support record third quarter premium instrument placements, driving 14% growth in global premium instrument installed baseDelivers EPS of $2.15, an increase of 6% as reported and 13% on a comparable basis supported by operating margin expansion of 120 basis points as reported and 100 basis points on a comparable basis Adjusts 20
Oct 11, 2022 03:15 pm ET
IDEXX Laboratories to Release 2022 Third Quarter Financial Results
WESTBROOK, Maine, Oct. 11, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 third quarter results for Tuesday, November 1, 2022 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Aug 02, 2022 06:30 am ET
IDEXX Laboratories Announces Second Quarter Results
Achieves second quarter revenue growth of 4% reported and 6.5% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 7% organic, building on high prior year growthSolid demand for diagnostic services and strong IDEXX execution support record second quarter premium instrument placements, driving 15% growth in global premium installed baseDelivers EPS of $1.56, representing declines of 33% as reported and 30% on a comparable basis, including $0.72 per share impact from discrete R&D investmentsAdjusts 2022 revenue guidance to 3% - 5.5% growth as reported and 5.5% -
Jun 21, 2022 07:00 am ET
IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases
IDEXX Reference Laboratories Will Add Fecal Dx Antigen Testing with Flea Tapeworm Detection, Testing for the FGF-23 Kidney Biomarker, and Next-Day PCR Direct Testing Service
Jun 21, 2022 07:00 am ET
IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases
IDEXX Reference Laboratories Will Add Fecal Dx Antigen Testing with Flea Tapeworm Detection, Testing for the FGF-23 Kidney Biomarker, and Next-Day PCR Direct Testing Service
May 18, 2022 02:30 pm ET
IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
WESTBROOK, Maine, May 18, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Jaws & Paws Conference on Wednesday, June 1, 2022. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:50 pm (EDT).
May 04, 2022 06:30 am ET
IDEXX Laboratories Announces First Quarter Results
Achieves first quarter revenue growth of 8% reported and organic, driven by CAG Diagnostics recurring revenue growth of 8% reported and 9% organic, building on high prior year growth Continued strong sector demand supports record first quarter premium instrument placements, driving CAG Diagnostics capital instrument revenue growth of 19% reported and 22% organic Delivers EPS of $2.27, representing 3% decline as reported and 3% growth on a comparable basis, reflecting comparisons to strong prior year results and increases in commercial investments Adjusts 2022 guidance to reflect moderated ve
Apr 11, 2022 03:00 pm ET
IDEXX Laboratories to Release 2022 First Quarter Financial Results
WESTBROOK, Maine, April 11, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2022 first quarter results for Wednesday, May 4, 2022 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Feb 17, 2022 02:00 pm ET
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
WESTBROOK, Maine, Feb. 17, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:
Feb 02, 2022 05:30 am ET
IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
WESTBROOK, Maine, Feb. 2, 2022 /PRNewswire/ --
Jan 13, 2022 08:00 am ET
PetDx and IDEXX Expand Access to OncoK9, the Cancer Liquid Biopsy Test for Dogs
SAN DIEGO, Jan. 13, 2022 /PRNewswire/ -- PetDx® – The Liquid Biopsy Company for Pets™, dedicated to unleashing the power of genomics to improve pet health, announced today a collaboration with IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, to significantly broaden access to canine cancer liquid biopsy testing. 
Jan 13, 2022 06:05 am ET
IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency and Faster, More Confident Clinical Decisions
WESTBROOK, Maine, Jan. 13, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced today a series of product and service enhancements that enable veterinary practices to be more efficient, while managing increasing patient volumes. The enhancements provide deeper, actionable insights and personalized support to facilitate faster, more confident clinical decisions.
Jan 13, 2022 06:00 am ET
IDEXX Enables Improved Cancer Diagnosis and Personalized Care through Expanded Oncology Offering
WESTBROOK, Maine, Jan. 13, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced today the expansion of its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. Building on its expertise in cancer pathology, IDEXX continues to expand what's possible to enhance the lives of pets by providing veterinarians with comprehensive cancer diagnostics and support services.
Jan 11, 2022 02:15 pm ET
IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results
WESTBROOK, Maine, Jan. 11, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 fourth quarter and full year financial results for Wednesday, February 2, 2022 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Nov 02, 2021 06:30 am ET
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine, Nov. 2, 2021 /PRNewswire/ -- 
Oct 08, 2021 04:15 pm ET
IDEXX Laboratories to Release 2021 Third Quarter Financial Results
WESTBROOK, Maine, Oct. 8, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 third quarter financial results for Tuesday, November 2, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Aug 09, 2021 03:30 pm ET
IDEXX Laboratories to Host Virtual Investor Day
WESTBROOK, Maine, Aug. 9, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2021 virtual Investor Day on Thursday, August 12, 2021 from 10:00 am to approximately 12:30 pm EDT.
Jul 30, 2021 06:30 am ET
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, July 30, 2021 /PRNewswire/ --
Jun 30, 2021 04:05 pm ET
IDEXX Laboratories to Release 2021 Second Quarter Financial Results
WESTBROOK, Maine, June 30, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 second quarter financial results for Friday, July 30, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jun 02, 2021 04:25 pm ET
IDEXX Acquires ezyVet
Global leader in veterinary diagnostics and software enhances its practice management portfolio with acquisition of leading cloud-based solution
Feb 16, 2021 03:30 pm ET
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
WESTBROOK, Maine, Feb. 16, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:
Feb 02, 2021 05:30 am ET
IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/ -- 
Jan 28, 2021 06:30 am ET
­­IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative
Advancing diversity in veterinary medicine through nine full scholarships and integrated support
Jan 28, 2021 06:30 am ET
­­IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative
Advancing diversity in veterinary medicine through nine full scholarships and integrated support
Jan 11, 2021 01:00 pm ET
IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
WESTBROOK, Maine, Jan. 11, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 fourth quarter and full-year financial results for Tuesday, February 2, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Nov 12, 2020 06:30 am ET
IDEXX Laboratories Elects Dr. Asha S. Collins to Board of Directors
WESTBROOK, Maine, Nov. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today the election of Dr. Asha S. Collins, Head of U.S. Clinical Operations of Genentech, a biotechnology company and member of the Roche Group, to the Company's Board of Directors, effective November 11, 2020.
Oct 29, 2020 06:30 am ET
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine, Oct. 29, 2020 /PRNewswire/ -- 
Aug 12, 2020 07:32 am ET
Aug 12, 2020 07:30 am ET
IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with dramatically simplified user experience
Fast, effortless operation and a small footprint make consistent, accurate in-clinic hematology results accessible to veterinarians worldwide
Jul 31, 2020 06:30 am ET
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, July 31, 2020 /PRNewswire/ --
Jul 20, 2020 01:00 pm ET
IDEXX Laboratories to Release 2020 Second Quarter Financial Results and Host Virtual Investor Day
WESTBROOK, Maine, July 20, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 second quarter financial results for Friday, July 31, 2020 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jun 05, 2020 07:00 am ET
OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
ROSWELL, Ga., and WESTBROOK, Maine, June 5, 2020 /PRNewswire/ -- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that it has received the CE mark certification in the European Union for its OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. This announcement follows earlier validation of the test by the Institut Pasteur of France as well as Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA).
May 26, 2020 05:00 pm ET
IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update
WESTBROOK, Maine, May 26, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends through Friday, May 22nd.
May 18, 2020 01:30 pm ET
IDEXX Laboratories to Present at Stifel Conference
WESTBROOK, Maine, May 18, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, May 27, 2020. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at 9:45 am EDT.
May 07, 2020 07:30 am ET
OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
ROSWELL, Ga., and WESTBROOK, Maine, May 7, 2020 /PRNewswire/ -- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. This announcement follows earlier validation of the test by the Institut Pasteur of France.
Apr 30, 2020 06:30 am ET
IDEXX Laboratories Announces First Quarter Results
WESTBROOK, Maine, April 30, 2020 /PRNewswire/ --
Apr 20, 2020 07:30 am ET
IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians
Response to growing clinical evidence, rare but real cases, and requests from veterinarians worldwide
Apr 20, 2020 07:30 am ET
IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians
Response to growing clinical evidence, rare but real cases, and requests from veterinarians worldwide
Apr 14, 2020 11:00 am ET
IDEXX Laboratories to Release 2020 First Quarter Financial Results
WESTBROOK, Maine, April 14, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 first quarter financial results for Thursday, April 30, 2020 before the market opens. The Company will host a conference call beginning at 8:30 a.m. ET on that day.
Mar 13, 2020 07:30 am ET
Leading Veterinary Diagnostic Company Sees No COVID-19 Cases in Pets
Thousands of canine and feline specimens tested surfaced no positive results to date 
Jan 17, 2020 06:30 am ET
IDEXX Launches Rapid Digital Cytology Service to Further Accelerate Delivery of Veterinary Healthcare
Enables faster veterinary clinical decision-making, rapid case management, and enhanced client experience
Jan 17, 2020 06:30 am ET
Latest IDEXX Innovations Designed to Enhance Patient Care and Drive Veterinary Productivity
SediVue Dx® with Advanced Bacteria Detection, new Catalyst® Bile Acids Test, and IDEXX Web PACS™ diagnostic imaging software advancements empower veterinarians for faster, more confident diagnoses
Oct 31, 2019 06:30 am ET
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine, Oct. 31, 2019 /PRNewswire/ --
Oct 24, 2019 07:30 am ET
IDEXX Laboratories Announces Leadership Changes
WESTBROOK, Maine, Oct. 24, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Jonathan Ayers is stepping down as Chairman and a member of the IDEXX management team, effective November 1, 2019. This decision follows Mr. Ayers's previously announced medical leave of absence from IDEXX due to a bicycling accident, where he suffered a spinal cord injury.
Oct 10, 2019 01:30 pm ET
IDEXX Laboratories to Release 2019 Third Quarter Financial Results
WESTBROOK, Maine, Oct. 10, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 third quarter financial results for Thursday, October 31, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Oct 02, 2019 07:30 am ET
IDEXX Breakthrough Kidney Function Test Now Key Component of IRIS Staging Guidelines
New guidelines enhance the ability of veterinarians to assess renal function 
Oct 02, 2019 07:30 am ET
IDEXX Breakthrough Kidney Function Test Now Key Component of IRIS Staging Guidelines
New guidelines enhance the ability of veterinarians to assess renal function 
Aug 06, 2019 02:00 pm ET
IDEXX Laboratories to Host 2019 Investor Day
WESTBROOK, Maine, Aug. 6, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2019 Investor Day on August 14-15, 2019 at its corporate headquarters in Westbrook, Maine. A live audio webcast and accompanying slide presentations will be available at www.idexx.com/investors. An archived webcast replay of the event will be available approximately one hour following each event at www.idexx.com/investors.
Aug 01, 2019 06:30 am ET
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, Aug. 1, 2019 /PRNewswire/ --
Jul 18, 2019 04:00 pm ET
IDEXX Laboratories Elects Sam Samad to Board of Directors
WESTBROOK, Maine, July 18, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today the election of Sam Samad, the Senior Vice President and Chief Financial Officer of Illumina, Inc., as a member of the Company's Board of Directors, effective July 16, 2019.
Jul 15, 2019 02:00 pm ET
IDEXX Laboratories to Release 2019 Second Quarter Financial Results
WESTBROOK, Maine, July 15, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 second quarter financial results for Thursday, August 1, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jul 01, 2019 08:30 am ET
IDEXX Laboratories Chairman, President and Chief Executive Officer, Jonathan Ayers, Taking Medical Leave of Absence
WESTBROOK, Maine, July 1, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Chairman, President and Chief Executive Officer, Jonathan Ayers, is on a medical leave of absence following a serious bicycling accident that occurred on June 27, 2019.
May 20, 2019 03:00 pm ET
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
WESTBROOK, Maine, May 20, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:
May 01, 2019 06:30 am ET
IDEXX Laboratories Announces First Quarter Results
WESTBROOK, Maine, May 1, 2019 /PRNewswire/ -- 
Apr 23, 2019 06:00 am ET
IDEXX CEO Establishes Wild Cat Conservation Foundation
WESTBROOK, Maine, April 23, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that its Chairman and Chief Executive Officer, Jonathan Ayers, and his wife, Helaine, have established a foundation that will support conservation of the estimated 40 species of felids in the wild. The Ayers Wild Cat Conservation Trust is endowed by a gift of IDEXX stock from the Ayers family. The foundation will focus on supporting the funding of global wild cat species conservation initiatives and organizations.
Apr 12, 2019 08:00 am ET
Factors of Influence in 2019, Key Indicators and Opportunity within IDEXX Laboratories, Aegion, NetScout, Castlight Health, inc, Leap Therapeutics, and Speedway Motorsports — New Research Emphasizes E
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IDEXX Laboratories, Inc. (NASDAQ:IDXX), Aegion Corporation...
Apr 02, 2019 11:30 am ET
IDEXX Laboratories to Release 2019 First Quarter Financial Results
WESTBROOK, Maine, April 2, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 first quarter financial results for Wednesday, May 1, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Mar 04, 2019 06:30 am ET
IDEXX Names Sharon Underberg General Counsel
WESTBROOK, Maine, March 4, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Sharon Underberg has been appointed the Company's Corporate Vice President, General Counsel, and Corporate Secretary, effective March 1, 2019. In this role, Ms. Underberg leads IDEXX's global legal and compliance teams, and the office of the Corporate Secretary. She succeeds Jacqueline Studer, who has been IDEXX's Corporate Vice President, General Counsel, and Corporate Secretary s
Feb 11, 2019 02:07 pm ET
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
WESTBROOK, Maine, Feb. 11, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:
Feb 01, 2019 05:27 am ET
IDEXX Laboratories Announces Fourth Quarter and Full Year 2018 Results
WESTBROOK, Maine, Feb. 1, 2019 /PRNewswire/ --
Jan 24, 2019 08:10 am ET
Consolidated Research: 2019 Summary Expectations for First Data, IDEXX Laboratories, CMS Energy, Worthington Industries, Triumph Group, and Cara Therapeutics — Fundamental Analysis, Key Performance In
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of First Data Corporation (NYSE:FDC), IDEXX Laboratories, Inc....
Jan 21, 2019 06:32 am ET
IDEXX Expands SediVue Dx® Analyzer Medical Utility and Imaging Capabilities with Latest Software Update
WESTBROOK, Maine, Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced an update to its SediVue Dx® Urine Sediment Analyzer with its Neural Network 4.0 software release, expanding the analyzer's diagnostic capabilties. This update will be implemented across all SediVue Dx analyzer customers by the end of March, and reflects IDEXX's ongoing commitment to support the profession, advancing the standard of care with innovation. 
Jan 21, 2019 06:30 am ET
IDEXX Introduces Exclusive Point-of-Care Progesterone Test to Its Catalyst Platform
WESTBROOK, Maine, Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that it is introducing a new canine progesterone test for Catalyst Dx® and Catalyst One® chemistry analyzers. This much-anticipated in-house diagnostic will help veterinarians determine when a dog is ready to breed by providing a reliable, quantitative, point-of-care measure of progesterone levels to ascertain ovulation status. IDEXX will begin shipping the new test by the end of March, with initial availability in the United States,
Jan 09, 2019 03:20 pm ET
IDEXX Laboratories to Release 2018 Fourth Quarter and Full-Year Financial Results
WESTBROOK, Maine, Jan. 9, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 fourth quarter and full-year financial results for Friday, February 1, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Nov 12, 2018 08:30 am ET
Analysis: Positioning to Benefit within IDEXX Laboratories, Editas Medicine, Arconic, Cardtronics, Cloudera, and BMC Stock — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IDEXX Laboratories, Inc. (NASDAQ:IDXX), Editas Medicine, Inc....
Nov 01, 2018 06:30 am ET
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine, Nov. 1, 2018 /PRNewswire/ -- 
Oct 11, 2018 07:30 am ET
Market Trends Toward New Normal in Altra Industrial Motion, IDEXX Laboratories, BioTelemetry, Galectin Therapeutics, NETGEAR, and Merck & Co. — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Altra Industrial Motion Corp. (NASDAQ:AIMC), IDEXX Laboratories, Inc....
Sep 24, 2018 10:00 am ET
IDEXX Laboratories to Release 2018 Third Quarter Financial Results
WESTBROOK, Maine, Sept. 24, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 third quarter financial results for Thursday, November 1 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Sep 10, 2018 07:30 am ET
IDEXX Pseudalert Test Accepted as Global ISO Standard
WESTBROOK, Maine, Sept. 10, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), the global leader in rapid microbiological testing for water, today announced that the IDEXX Pseudalert® method has been published as the International Organization for Standardization (ISO) worldwide standard 16266-2 for the 24-hour detection of Pseudomonas aeruginosa in water. P. aeruginosa can cause life-threatening infections in hospitals and is a frequent cause of skin, ear, and eye infections from pool and spa water. Public and private laboratories and healthcare and hospitality industry fac
Sep 05, 2018 11:30 am ET
IDEXX Laboratories to Present at Bank of America Merrill Lynch Global Healthcare Conference
WESTBROOK, Maine, Sept. 5, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the Bank of America Merrill Lynch Global Healthcare Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Wednesday, September 12, 2018 at 4:10 p.m. BST (11:10 a.m. EDT), at the Bank of America Merrill Lynch Financial Centre, London, United Kingdom. Individuals can access the live
Aug 15, 2018 07:30 am ET
IDEXX Reference Laboratories Significantly Expands Rapid Overnight Service for Thousands of U.S. Veterinary Practices
WESTBROOK, Maine, Aug. 15, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that its U.S. reference laboratory division will significantly expand its rapid overnight service, known as IDEXX-Direct® service, for thousands of rural U.S. veterinary practices. Through a new, state-of-the-art reference laboratory in Louisville, Kentucky, IDEXX will provide thousands of veterinary hospitals across the country with additional flexibility by offering the latest possible patient sample pick-up time with next morning
Aug 06, 2018 02:00 pm ET
IDEXX Laboratories to Host 2018 Investor Day
WESTBROOK, Maine, Aug. 6, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2018 Investor Day on August 15-16, 2018 at its corporate headquarters in Westbrook, Maine. A live audio webcast and accompanying slide presentations will be available at www.idexx.com/investors. An archived webcast replay of the event will be available approximately one hour following each event at www.idexx.com/investors.
Aug 06, 2018 07:30 am ET
Detailed Research: Economic Perspectives on A10 Networks, Lannett, Navigant Consulting, EastGroup Properties, Lennox International, and IDEXX Laboratories — What Drives Growth in Today's Competitive L
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of A10 Networks, Inc. (NYSE:ATEN), Lannett Co Inc (NYSE:LCI), Navigant...
Aug 01, 2018 06:30 am ET
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, Aug. 1, 2018 /PRNewswire/ -- 
Jul 05, 2018 11:45 am ET
IDEXX Laboratories to Release 2018 Second Quarter Financial Results
WESTBROOK, Maine, July 5, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 second quarter financial results for Wednesday, August 1 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jun 05, 2018 11:35 am ET
IDEXX Laboratories to Present at William Blair Growth Stock Conference
WESTBROOK, Maine, June 5, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the William Blair 38th Annual Growth Stock Conference. Jonathan Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Tuesday, June 12, 2018 at 10:10 a.m. (Central Time), at the Four Seasons Hotel, Chicago, Illinois.  Individuals can access the live audio webcast of the presentation through a link on the IDEXX websi
May 21, 2018 04:26 pm ET
IDEXX Laboratories to Present at Stifel 2018 Dental and Veterinary Conference
WESTBROOK, Maine, May 21, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the Stifel Dental and Veterinary Conference. Jonathan Ayers, Chairman and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will present on Wednesday, May 30, 2018 at 8:00 a.m. (EDT), at the Peninsula Hotel, New York. Individuals can access the live audio webcast of the presentation through a link on the IDEXX web
May 04, 2018 06:30 am ET
IDEXX Laboratories Announces First Quarter Results
WESTBROOK, Maine, May 4, 2018 /PRNewswire/ --
Apr 30, 2018 08:15 am ET
Research Report Identifies Cara Therapeutics, MGE Energy, IDEXX Laboratories, Sterling Construction, TTM Technologies, and Regis with Renewed Outlook — Fundamental Analysis, Calculating Forward Moveme
NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cara Therapeutics, Inc. (NASDAQ:CARA), MGE Energy...
Apr 12, 2018 04:00 pm ET
IDEXX Laboratories to Release 2018 First Quarter Financial Results
WESTBROOK, Maine, April 12, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 first quarter financial results for Friday, May 4 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Feb 15, 2018 01:30 pm ET
IDEXX Laboratories to Present at Two Conferences
WESTBROOK, Maine, Feb. 15, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:
Feb 05, 2018 06:30 am ET
IDEXX Advances Power of SediVue Dx with Latest Software Update
Neural Network 3.0 Brings Machine Learning, 70 Million Images into the Veterinary Practice for Faster, More Accurate Urine Sediment Analysis
Feb 05, 2018 06:30 am ET
IDEXX Advances Power of SediVue Dx with Latest Software Update
Neural Network 3.0 Brings Machine Learning, 70 Million Images into the Veterinary Practice for Faster, More Accurate Urine Sediment Analysis
Feb 01, 2018 06:50 am ET
IDEXX Laboratories, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 1, 2018 / IDEXX Laboratories, Inc. (NASDAQ: IDXX) will be discussing their earnings results in their Q4 Earnings Call to be held on February 1, 2018 at 8:30 AM Eastern Time.
Feb 01, 2018 05:30 am ET
IDEXX Laboratories Announces Fourth Quarter and Full Year 2017 Results
WESTBROOK, Maine, Feb. 1, 2018 /PRNewswire/ --
Jan 18, 2018 01:59 pm ET
IDEXX Laboratories to Release 2017 Fourth Quarter and Full-Year Financial Results
WESTBROOK, Maine, Jan. 18, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2017 fourth quarter and full-year financial results for Thursday, February 1 at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jan 08, 2018 08:00 am ET
IDEXX to Introduce Applied BioCode’s Innovative Multiplex Technology Across Global Reference Laboratory Network
IDEXX Laboratories, Inc. (NASDAQ: IDXX) and Applied BioCode (6598:Taipei) today announced that they have entered into an exclusive global agreement to bring Applied BioCode’s digital multiplex platform to IDEXX Reference Laboratory customers. IDEXX anticipates the technology will be commercially available starting in 2019. Applied BioCode is a California-headquartered diagnostics company which designs, develops, manufactures, and markets systems for highly multiplexed assays.
Jan 08, 2018 06:32 am ET
IDEXX Launches SDMA in the Point of Care with IDEXX Catalyst® SDMA Test
Company Continues Innovation with a Collaboration with Yale University to Explore Human Health Applications and an Expanded Database of Kidney Information
Jan 08, 2018 06:32 am ET
IDEXX Launches SDMA in the Point of Care with IDEXX Catalyst® SDMA Test
Company Continues Innovation with a Collaboration with Yale University to Explore Human Health Applications and an Expanded Database of Kidney Information
Jan 08, 2018 06:30 am ET
IDEXX to Introduce Applied BioCode's Innovative Multiplex Technology Across Global Reference Laboratory Network
WESTBROOK, Maine, Jan. 8, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) and Applied BioCode (6598:Taipei) today announced that they have entered into an exclusive global agreement to bring Applied BioCode's digital multiplex platform to IDEXX Reference Laboratories customers. IDEXX anticipates the technology will be commercially available starting in 2019. Applied BioCode is a California-headquartered diagnostics company that designs, develops, manufactures, and markets systems for highly multiplexed assays.
Jan 05, 2018 08:20 am ET
Recent Analysis Shows Chimerix, Highwoods Properties, HubSpot, Biglari, IDEXX Laboratories, and Argan Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Chimerix, Inc. (NASDAQ:CMRX), Highwoods Properties, Inc....
Jan 05, 2018 06:00 am ET
IDEXX Laboratories Announces Estimated Impact of U.S. Tax Reform
WESTBROOK, Maine, Jan. 5, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. ("IDEXX" or the "Company") (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, expects the recently passed Tax Cuts and Jobs Act (the "Tax Legislation") to benefit the Company by reducing its recurring effective tax rate beginning in 2018 by approximately 750-850 basis points. The Company also estimates that the enactment of the Tax Legislation will result in a one-time reduction of approximately $35 million - $45 million in the Company's earnings for th
Jan 02, 2018 02:48 pm ET
IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference
WESTBROOK, Maine, Jan. 2, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the 36th Annual J.P. Morgan Healthcare Conference. Jonathan Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Wednesday, January 10, 2018 at 7:30 a.m. PT/10:30 a.m. ET, at the Westin St. Francis Hotel, San Francisco, California. Individuals can access the live audio webcast of the presentation and question-and-answer session following the presentation through a link on the home page of the IDEXX website, www.idexx.
Oct 31, 2017 08:00 am ET
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine, Oct. 31, 2017 /PRNewswire/ --
Oct 05, 2017 03:00 pm ET
IDEXX Laboratories to Release 2017 Third Quarter Financial Results
WESTBROOK, Maine, Oct. 5, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2017 third quarter financial results for Tuesday, October 31, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Sep 06, 2017 05:30 pm ET
IDEXX Laboratories to Present at Bank of America Merrill Lynch Global Healthcare Conference
WESTBROOK, Maine, Sept. 6, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the London Bank of America Merrill Lynch Global Healthcare Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Wednesday, September 13, 2017 at 1:45 p.m. BST (8:45 a.m. EDT), at the Bank of America Merrill Lynch Financial Centre, London, United Kingdom. Individuals can access th
Sep 05, 2017 08:00 am ET
Brian McKeon Joins athenahealth Board of Directors
WATERTOWN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN) a leading provider of network-enabled services for hospitals and physician groups, today announced the appointment of Brian McKeon, current IDEXX Laboratories, Inc. (NASDAQ:IDXX) chief financial officer, to its Board of Directors. In addition to joining the Board, Mr. McKeon will serve on the Audit Committee. With Mr. McKeon, the athenahealth Board has been expanded to 10 members....
Aug 08, 2017 05:00 pm ET
IDEXX Laboratories to Host 2017 Investor Day
WESTBROOK, Maine, Aug. 8, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2017 Investor Day on August 16-17, 2017 at its corporate headquarters in Westbrook, Maine. A live audio webcast and accompanying slide presentations will be available at www.idexx.com. An archived webcast replay of the event will be available approximately one hour following each event at www.idexx.com.
Aug 01, 2017 08:00 am ET
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, Aug. 1, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, reports revenues for the second quarter of 2017 of $509 million, an increase of 9% compared to the prior year period on a reported basis and 10% on an organic basis. Second quarter results were driven by robust global gains in Companion Animal Group ("CAG") Diagnostics recurring revenue, including double-digit organic revenue growth in consumables and reference lab services, and solid growth in
Jul 17, 2017 05:15 pm ET
IDEXX Laboratories Elects Stuart M. Essig to Board of Directors
WESTBROOK, Maine, July 17, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced the unanimous election of Stuart M. Essig as a member of the Company's Board of Directors, effective July 12, 2017. In connection with Dr. Essig's election, the Board also increased its size from 8 to 9 members, effective July 12, 2017.
Jul 10, 2017 02:08 pm ET
IDEXX Laboratories to Release 2017 Second Quarter Financial Results
WESTBROOK, Maine, July 10, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2017 second quarter financial results for Tuesday, August 1, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jun 01, 2017 04:00 pm ET
IDEXX Laboratories to Present at William Blair Growth Stock Conference
WESTBROOK, Maine, June 1, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the William Blair 37th Annual Growth Stock Conference. Jonathan Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Tuesday, June 13, 2017 at 10:50 a.m. (Central Time), at the Four Seasons Hotel, Chicago, Illinois.  Individuals can access the live audio webcast of the presentation through a link on the home page o
May 17, 2017 04:00 pm ET
IDEXX Laboratories to Present at Stifel 2017 Dental and Veterinary Conference
WESTBROOK, Maine, May 17, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the Stifel Dental and Veterinary Conference. Jay Mazelsky, Executive Vice President, and Brian McKeon, Executive Vice President and Chief Financial Officer, will present on Wednesday, May 31, 2017 at 12:40 p.m. (EDT), at the Peninsula Hotel, New York. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX
May 03, 2017 08:00 am ET
IDEXX Laboratories Announces Increase in Share Repurchase Program
WESTBROOK, Maine, May 3, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that the repurchase by the Company of up to an additional 3.0 million shares of its common stock under its ongoing share repurchase program has been authorized. Repurchases may be made in the open market (including through Rule 10b5-1 plans) or in negotiated transactions. These shares are in addition to the 3,297,887 shares remaining under the Company's share repurchase program as of Apri
Apr 28, 2017 08:00 am ET
IDEXX Laboratories Announces First Quarter Results
WESTBROOK, Maine, April 28, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, reports revenues for the first quarter of 2017 of $462 million, an increase of 11% compared to the prior year period on both a reported and an organic basis. First quarter results were driven by robust global gains in Companion Animal Group ("CAG") Diagnostics recurring revenue, including double-digit organic revenue gains across consumable, reference lab and rapid assay revenues, as well as continued
Apr 06, 2017 04:00 pm ET
IDEXX Laboratories to Release 2017 First Quarter Financial Results
WESTBROOK, Maine, April 6, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2017 first quarter financial results for Friday, April 28, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Mar 20, 2017 09:00 am ET
IDEXX Laboratories Joins the NASDAQ-100 Index
WESTBROOK, Maine, March 20, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX) announced that it joined the NASDAQ-100 Index® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE), and the NASDAQ-100 Ex Technology Index (Nasdaq: NDXX) prior to market open today.
Mar 10, 2017 08:00 pm ET
IDEXX Laboratories, Inc. to Join the NASDAQ-100 Index Beginning March 20, 2017
NEW YORK, March 10, 2017 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) today announced that IDEXX Laboratories, Inc. (Nasdaq:IDXX), will become a component of the NASDAQ-100 Index® (Nasdaq:NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq:NDXE) and the NASDAQ-100 Ex Technology Index (Nasdaq:NDXX) prior to market open on Monday, March 20, 2017. IDEXX Laboratories, Inc. will replace SBA Communications Corporation (Nasdaq:SBAC) which is being removed as a result of their conversion to a REIT....
Feb 27, 2017 03:49 pm ET
IDEXX Laboratories to Present at Raymond James Institutional Investors Conference
WESTBROOK, Maine, Feb. 27, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the Raymond James 38th Annual Institutional Investors Conference. Jonathan Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Monday, March 6, 2017 at 10:25 a.m. (ET), at the JW Marriott Orlando Grande Lakes, Orlando, Florida. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archived edition of the presentation wil
Feb 02, 2017 07:00 am ET
IDEXX Laboratories Announces Fourth Quarter and Full Year 2016 Results
WESTBROOK, Maine, Feb. 2, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, reports revenues for the fourth quarter of 2016 of $443 million, an increase of 11% compared to the prior year period on a reported basis and 12% on an organic basis. Fourth quarter results were supported by accelerated gains in Companion Animal Group ("CAG") Diagnostics recurring revenue and continued high growth in premium instrument placements. Earnings per diluted share ("EPS") was $0.58 for the fou
Jan 18, 2017 01:30 pm ET
IDEXX Laboratories to Release 2016 Fourth Quarter and Full-Year Financial Results
WESTBROOK, Maine, Jan. 18, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2016 fourth quarter and full-year financial results for Thursday, February 2, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jan 04, 2017 09:58 am ET
IDEXX Laboratories to Join S&P 500 Index
WESTBROOK, Maine, Jan. 4, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced that it has been named to the S&P 500® and will join after close of trading today. The world-renowned index includes 500 of the top companies in leading industries of the U.S. economy.
Jan 03, 2017 06:35 pm ET
IDEXX Laboratories Set to Join the S&P 500; Chemours to Join S&P MidCap 400; Shake Shack to Join S&P SmallCap 600
NEW YORK, Jan. 3, 2017 /PRNewswire/ -- S&P MidCap 400 constituent IDEXX Laboratories, Inc. (NASD: IDXX) will replace St. Jude Medical, Inc. (NYSE: STJ) in the S&P 500, S&P SmallCap 600 constituent The Chemours Company (NYSE: CC) will replace IDEXX in the S&P MidCap 400, and Shake Shack Inc. (NYSE: SHAK) will replace Chemours in the S&P SmallCap 600 after the close of trading on Wednesday, January 4. S&P 100 & 500 constituent Abbott Laboratories (NYSE: ABT) is acquiring St. Jude Medical in a deal expected to be completed on or about that date, pending final conditi
Dec 20, 2016 03:34 pm ET
IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference
WESTBROOK, Maine, Dec. 20, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the 35th Annual J.P. Morgan Healthcare Conference. Jonathan Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Wednesday, January 11, 2017 at 3:00 p.m. PT/6:00 p.m. ET, at the Westin St. Francis Hotel, San Francisco, California. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX website, www.idexx.com. An archived edition of the presentation will be av
Nov 15, 2016 04:15 pm ET
IDEXX Laboratories Announces Departure of Executive Vice President Michael Williams
WESTBROOK, Maine, Nov. 15, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), the global leader in veterinary diagnostics, software, and water microbiology testing, announced today that Michael J. Williams, Ph.D., Executive Vice President, is departing from the Company in February of next year and stepping down from his current role in November 2016. Dr. Williams has been Executive Vice President since 2012 and has been employed by the Company since 2003.
Nov 14, 2016 07:30 am ET
IDEXX Welcomes Healthcare Technology Veteran Pat Venters as Chief Marketing Officer
WESTBROOK, Maine, Nov. 14, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), the global leader in veterinary diagnostics, software, and water microbiology testing, today announced that Pat Venters has joined the company as Vice President and Chief Marketing Officer. Venters will be responsible for the company's commercial marketing efforts, including global responsibility for its marketing centers of excellence. Venters' role includes support of demand generation initiatives, market research and analytics, digital and social marketing, and brand and marketing communications."Pat
Nov 01, 2016 08:00 am ET
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine, Nov. 1, 2016 /PRNewswire/ --
Oct 28, 2016 03:00 pm ET
IDEXX Laboratories to Present at Credit Suisse Healthcare Conference
WESTBROOK, Maine, Oct. 28, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the 25th Annual Credit Suisse Healthcare Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Tuesday, November 8, 2016 at 2:30 pm MST, at The Phoenician in Scottsdale, Arizona. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via the sa
Oct 19, 2016 05:15 pm ET
IDEXX Laboratories Elects Lawrence D. Kingsley to Board of Directors
WESTBROOK, Maine, Oct. 19, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced the unanimous election of Lawrence D. Kingsley as a member of the Company's Board of Directors, effective today. In connection with Mr. Kingsley's election, the Board also increased its size from 9 to 10, effective today.
Oct 11, 2016 04:38 pm ET
IDEXX Laboratories to Release 2016 Third Quarter Financial Results
WESTBROOK, Maine, Oct. 11, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2016 third quarter financial results for Tuesday, November 1, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Sep 06, 2016 03:01 pm ET
IDEXX Laboratories to Present at Raymond James North American Equities Conference
WESTBROOK, Maine, Sept. 6, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the Raymond James 12th Annual North American Equities Conference. Michael Williams, PhD, Executive Vice President, is scheduled to make a presentation on the Company on Tuesday, September 13, 2016 at 12:45 p.m. BST/7:45 a.m. EDT, at the Four Seasons Hotel London at Park Lane, London, England. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presen
Aug 08, 2016 06:00 pm ET
IDEXX Laboratories to Host 2016 Investor Day
WESTBROOK, Maine, Aug. 8, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) will host its 2016 Investor Day on August 17-18, 2016 at its corporate headquarters in Westbrook, Maine. A live audio webcast and accompanying slide presentations will be available at www.idexx.com. An archived webcast replay of the event will be available approximately one hour following each event at www.idexx.com.
Aug 02, 2016 08:00 am ET
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, Aug. 2, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported revenues for the second quarter of 2016 of $467 million, an increase of 13% compared to the prior year period. Organic revenue growth for the quarter was also 13%, supported by strong growth in the Companion Animal Group ("CAG") and Water segments.
Jul 27, 2016 12:41 pm ET
IDEXX Releases Revolutionary Water Test to Aid in the Fight Against Legionnaires' Disease
Legiolert™radically simplifies Legionella water testing compared to current culture methods
Jul 27, 2016 09:04 am ET
IDEXX Releases Revolutionary Water Test to Aid in the Fight Against Legionnaires' Disease
WESTBROOK, Maine, July 27, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced the availability of Legiolert, the easiest culture method for the confirmed detection of Legionella pneumophila in drinking water. Legionella pneumophila is the most common Legionella species in water and the primary cause of Legionnaires' disease.1 This month marks the 40th anniversary of the first outbreak of Legionnaires' disease in Philadelphia,2 which prompted one of the largest respiratory disease investigations in U.S. history. Legionnaires' disease is deadly for about 1 in 10 peopl
Jul 11, 2016 03:00 pm ET
IDEXX Laboratories to Release 2016 Second Quarter Financial Results
WESTBROOK, Maine, July 11, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2016 second quarter financial results for Tuesday, August 2, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Jun 21, 2016 08:30 am ET
IDEXX Leads the Veterinary Industry with the First Low-Dose Radiography System
WESTBROOK, Maine, June 21, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced the ImageVue™ DR50 Digital Imaging System, the first radiography system in veterinary medicine to enable low-dose radiation image capture without sacrificing clear, high-quality diagnostic images. Reduction in radiation exposure is critically important to the health and well-being of pets and veterinary professionals, especially veterinary technicians of childbearing age. Early adopters of the system reported the ability to use 40 percent to 50 percent less radiation than conventional syst
Jun 07, 2016 08:30 am ET
IDEXX Launches New Rapid Pregnancy Test for Cattle
WESTBROOK, Maine, June 7, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today the launch of the Rapid Visual Pregnancy Test for cattle, a point-of-care test that can detect an open cow 28 days post-breeding, improving reproductive efficiency and profitability. With the new test, veterinarians can more quickly and accurately identify open cows using whole blood samples collected before the farm visit, enabling veterinarians to provide value-added medical consulting services while on farm.
Jun 06, 2016 04:00 pm ET
IDEXX Laboratories to Present at William Blair 36th Annual Growth Stock Conference
WESTBROOK, Maine, June 6, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the William Blair 36th Annual Growth Stock Conference. Jonathan W. Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Tuesday, June 14, 2016 at 11:30 a.m. (Central Time), at the Four Seasons Hotel, Chicago, Illinois. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via t
Apr 29, 2016 08:00 am ET
IDEXX Laboratories Announces First Quarter Results
WESTBROOK, Maine, April 29, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported revenues for the first quarter of 2016 of $418 million, an increase of 9% compared to the prior year period. Organic revenue growth for the quarter was 11%, supported by strong growth in the Companion Animal Group ("CAG") and Water segments.
Apr 12, 2016 05:03 pm ET
IDEXX Laboratories to Release 2016 First Quarter Financial Results
WESTBROOK, Maine, April 12, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2016 first quarter financial results for Friday, April 29, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Feb 29, 2016 04:21 pm ET
IDEXX Laboratories to Present at Raymond James Institutional Investors Conference
WESTBROOK, Maine, Feb. 29, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the Raymond James 37th Annual Institutional Investors Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Tuesday, March 8, 2016 at 2:15 p.m. (EST), at the JW Marriott Grande Lakes, Orlando, Florida. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archived edition of the presentat
Feb 12, 2016 07:00 am ET
IDEXX Laboratories Announces Executive Vice President Johnny Powers to Retire in May 2016
WESTBROOK, Maine, Feb. 12, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that Johnny D. Powers, Ph.D., Executive Vice President, will be retiring from the Company in May 2016 and has stepped down from his current position effective February 8, 2016. Dr. Powers has been Executive Vice President since 2012 and has been employed by the Company since 2009.
Jan 29, 2016 07:00 am ET
IDEXX Laboratories Announces Fourth Quarter and Full Year 2015 Results
WESTBROOK, Maine, Jan. 29, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported revenues for the fourth quarter of 2015 of $400 million, an increase of 14%1 compared to the prior year period. Normalized organic revenue growth2 for the quarter was over 11%, supported by strong growth in the Companion Animal Group ("CAG") segment. Revenue for the full year of $1,602 million increased 8% on a reported basis, supported by 11% normalized organic revenue growth.
Jan 21, 2016 03:41 pm ET
IDEXX Laboratories to Release 2015 Fourth Quarter and Full-Year Financial Results
WESTBROOK, Maine, Jan. 21, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2015 fourth quarter and full-year financial results for Friday, January 29, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.